Patents
Patents for C07C 69 - Esters of carboxylic acids; Esters of carbonic or haloformic acids (54,756)
10/2004
10/27/2004CN1172910C Process for preparing VA derivative
10/27/2004CN1172900C Preparation method of malonate
10/27/2004CN1172899C Process for producing ethyl-acetate from synthetic gas through ethanol and acetic acid
10/27/2004CN1172898C Process for recovery of diacid ester from waste lye from preparation of caprolactam
10/26/2004US6809218 Sol-gel derived porous microcomposite of perfluorinated ion-exchange polymer and metal oxide
10/26/2004US6809217 Process for the preparation of ethyl acetate
10/26/2004US6809216 Waterproofing, oil repellents, antisoilants
10/26/2004US6809176 Compounds for use in treatment of cancer
10/26/2004US6808603 Radiating with polarized light to excite starting material; concentrating enantiomorphs or diastereomers; photochemically reversible
10/26/2004CA2198837C Process for the preparation of pure alkyl alkylacetoacetates
10/21/2004WO2004091210A1 Moving picture processing device, information processing device, and program thereof
10/21/2004WO2004091202A1 Moving picture processing device, information processing device, and program thereof
10/21/2004WO2004091201A1 Moving picture processing device, information processing device, and program thereof
10/21/2004WO2004089890A2 Process and intermediates for preparing benzazepines
10/21/2004WO2004089885A1 Novel compounds
10/21/2004WO2004089868A1 Amorphous simvastatin calcium and methods for the preparation thereof
10/21/2004WO2004071106A3 Method for storing and transmitting data generated by a security module
10/21/2004WO2004069969A3 Esters of conjugated unsaturated acids (conjugated acid esters), corresponding methods and use
10/21/2004US20040210087 Process for preparing carboxylic acids and derivatives thereof
10/21/2004US20040210082 In the first step, a 2-adamantanone is reacted with an alkyl halide in the presence of lithium metal to form an adamantanolate intermediate that is then reacted with an acrylic ester in the second step; does not require an organometallic agent in advance and is highly simplified in its production steps
10/21/2004US20040210081 Carboxylic esters based on 2-hydroxymethylnorbornane
10/21/2004US20040210078 synergistic mixtures with phenols or phenothiazines; (meth)acrylic acid, (meth)acrolein, vinyl aromatics, (meth)acrylic esters, (meth)acrylonitrile, (meth)acrylamide, olefins, or C4 to C8 conjugated dienes; nitrilotris(acetamidoxime) or nitrilotris(propionamidoxime); polymerization inhibition
10/21/2004US20040210077 cosmetics, lipsticks, cream foundations, waterproof sunscreens, sunscreen lotions
10/21/2004US20040210076 Carene epoxide intermediate that has been used as a precursor to tetrahydrocannabinoids
10/21/2004US20040209951 Novel resveratrol analogs
10/21/2004US20040209949 Resorcinol derivatives
10/21/2004US20040209847 treating and preventing a variety of diseases and conditions such as aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic retinopathy, dyslipidemia, dyslipoproteinemia, hypertension, impotence, insulin resistance, peroxisome proliferator activated receptor associated disorders
10/21/2004US20040209796 Fruity musk compositions
10/21/2004US20040209202 Fluorinated oxyvinyl compounds
10/21/2004US20040208904 Products for preventing penetration into the skin
10/21/2004US20040208816 Fullerene whisker and production process for fullerene whisker
10/21/2004DE10313228A1 Synthese von 2-Chlormethyl-6-methylbenzoesäureestern Methylbenzoesäureestern 2-chloromethyl-6-Synthesis of
10/21/2004CA2521095A1 Amorphous simvastatin calcium and methods for the preparation thereof
10/20/2004EP1468982A1 Carboxylic acid esters on basis of 2-hydroxy-methyl-norbornane
10/20/2004EP1468981A1 Production method of adamantyl acrylate compounds
10/20/2004EP1468979A1 Process for preparing S-(-)-chlorosuccinic acid
10/20/2004EP1468978A1 Process for producing (1S,6R)-2,2,6-trimethylcyclohexyl methyl ketone and/or (1R,6S)-2,2,6-trimethylcyclohexyl methyl ketone
10/20/2004EP1303471A4 Highly selective shell impregnated catalyst of improved space time yield for production of vinyl acetate
10/20/2004EP1112120B1 Process and catalyst for making dialkyl carbonates
10/20/2004CN1538965A Fungicidal 1-benzoxepin derivatives
10/20/2004CN1538947A Improvement to methods for continuous production of acetic acid and/or methyl acetate
10/20/2004CN1538946A Flexible method for common production of formic acid, carboxylic acid having at least two carbon atoms, and/or derivatives of the same
10/20/2004CN1538876A Novel catalytic formulation and its preparation method
10/20/2004CN1538870A Use of membranes to separate organic liquids having different polarities
10/20/2004CN1537935A 培养物 Culture
10/20/2004CN1537846A Intermediates for making HIV-protease inhibitors and method for making HIV-protease inhibitors
10/20/2004CN1537843A Carboxylic acid esters on basis of 2-hydroxy-methyl-norbornane
10/20/2004CN1537842A Propylene slycol mone methyl ether propionate composition and its preparation method and use
10/20/2004CN1171851C Diterpene compound and its prepn and use
10/20/2004CN1171850C Diterpene compound and its prepn and use
10/20/2004CN1171849C Process for preparing monomethyl fumarate
10/20/2004CN1171848C Method for producing vinyl acetate
10/20/2004CN1171847C Method for preparing lactic acid ester composition and use thereof as solvent
10/20/2004CN1171846C Diterpene derivatives and anti-inflammatory analgesic agents comprising the same
10/19/2004US6806382 Forming a catalyst support by impregnating silica particles with a catalytical active metal compound and a reducing agent to deposite the metal; esterification of ethylene and acetic acid to form vinyl acetate
10/19/2004US6806357 Fluorous nucleophilic substitution of alcohols and reagents for use therein
10/19/2004US6806264 Arylphenyl-substituted cyclic ketoenols
10/19/2004US6805920 Polymerizable liquid crystal compound and optical film
10/19/2004CA2081315C Heterocyclic chiral ligands and method for catalytic asymmetric dihydroxylation of olefins
10/14/2004WO2004087935A2 Fermentation process for the preparation of pravastatin
10/14/2004WO2004087636A1 Dicarboxylic acid monoester compound, method for producing same and polymer thereof
10/14/2004WO2004071416A3 Novel inhibitors of formation of advanced glycation endproducts (ages)
10/14/2004WO2004071401A3 Hydroxamic acid derivatives as histone deacetylase inhibitors (hdca)
10/14/2004US20040204618 Method for producing a fluorine-containing compound
10/14/2004US20040204606 Batch processing; washing of catalyst between batches
10/14/2004US20040204599 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions
10/14/2004US20040204596 preventing or treating degradation of collagen, degradation of collagen by bacterial collagenases during a bacterial infection, regeneration of skin and ligaments, tumoral invasion and degenerative diseases having fibrinoid degeneration of collagen
10/14/2004US20040204594 S-(+)-4-Methoxy-6-phenethyl-5,6-dihydro-pyran-2-one; plant extracts for nutraceutical foods, topical ointments
10/14/2004US20040204494 Having anticancer, anti-proliferous and anti-inflammatory effects and immunosuppressive and muscle relaxing functions
10/14/2004CA2521276A1 Fermentation process for the preparation of pravastatin
10/13/2004EP1466886A2 New salts of HMG-CoA reductase inhibitors
10/13/2004EP1465859A1 Method for the continuous production of alkyl (meth)acrylates
10/13/2004EP1465858A2 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity
10/13/2004EP1465848A2 Mixture of alicyclic polycarboxylic acid esters having a high cis isomer content
10/13/2004EP1465615A1 Tricyclic-bis-enone derivatives and methods of use thereof
10/13/2004EP1206436B1 Retinoids for the treatment of emphysema
10/13/2004CN1537094A Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities
10/13/2004CN1537093A Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc.
10/13/2004CN1537087A Method for producing monocarbonyl compounds or biscarbonyl compound or hydroxyl compounds
10/13/2004CN1535956A Substituted phenyl keto-enol pesticide and weedicide
10/13/2004CN1535949A Method for preparing ortho-methyl cyclohexyl acetate
10/13/2004CN1171348C Electrolytic solution and device for generating electric energy therewith
10/13/2004CN1171125C Copolymer with nitrile and alcyl group and photoresist composition containing the copolymer
10/13/2004CN1170904C Energy-curable composition for making pressure sensitive adhesive
10/13/2004CN1170808C Liquid crystal compound
10/13/2004CN1170595C Use of hydroxylated carboxylate or amide used as solubilizing agent
10/12/2004US6803488 Dehydrofluorination, deesterification, by-product inhibition; high molecular weight esters soluble in solvent, fluorination in liquid phase
10/12/2004US6803429 Selective ring-opening cross-metathesis of cycloolefins
10/12/2004US6803170 Resist composition and method for manufacturing semiconductor device using the resist composition
10/12/2004CA2325410C Synthesis of higher polyol fatty acid polyesters by transesterification
10/12/2004CA2170394C Process for conditioning substances
10/07/2004WO2004085377A1 Synthesis of 2-chloromethyl-6-methylbenzoic acid esters
10/07/2004WO2004085373A1 Novel shogaol compound and tyrosinase activity inhibitor comprising the compound
10/07/2004WO2004084632A1 Fungicides containing methoxy acrylic acid methyl ester compound
10/07/2004WO2004084631A1 Use of aromatic hydroxy compounds as safeners
10/07/2004WO2004052282A3 Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents
10/07/2004US20040198983 including fexofenadine; novel synthetic intermediate 2-(4-{4-(Hydroxydiphenyl-methyl)-piperidine-1-yl]-4-oxo-butyryl}-phenyl)-2-2-methyl-propionic Acid lower alkyl ester
10/07/2004US20040198825 Antidiabetic agents; side effect reduction
10/07/2004US20040198814 prevention , therapy of cardiovascular disorders, dyslipidemias, glucose metabolism, hypoglycemic agents; reduce fat concentration in meat; reduce cholesterol concentration in eggs
10/07/2004US20040198727 Compounds that abrogate DNA-damage-induced cell cycle G2 checkpoint and/or augment the anti-cancer activity of DNA damaging treatments